Protease Inhibitor Coinfusion with Amyloid β-Protein Results in Enhanced Deposition and Toxicity in Rat Brain

作者: Sally A. Frautschy , David L. Horn , Jason J. Sigel , Marni E. Harris-White , John J. Mendoza

DOI: 10.1523/JNEUROSCI.18-20-08311.1998

关键词:

摘要: Amyloid β-protein, Aβ, is normally produced in brain and cleared by unknown mechanisms. In Alzheimer’s disease (AD), Aβ accumulates plaque-like deposits implicated genetically neurodegeneration. Here we investigate mechanisms for degradation toxicity vivo , focusing on the effects of Aβ40, which peptide that apolipoprotein E4-associated AD. Chronic intraventricular infusion Aβ40 into rat resulted limited deposition toxicity. Coinfusion with cysteine protease inhibitor leupeptin increased extracellular intracellular immunoreactivity. Analysis gliosis TUNEL neuron layers frontal entorhinal cortex suggested exacerbated This was supported further neuronal staining cathepsin B endosomes or lysosomes, colocalizing immunoreactivity pyknotic cells. Leupeptin plus caused but significant phospho-tau immunostaining cortex. Intriguingly, induced accumulation more toxic Aβ42, a small group septal neurons. previously has been reported to interfere lysosomal proteolysis result lipofuscin, dystrophic neurites, tau- ubiquitin-positive inclusions, structures resembling paired helical filaments. serine aprotinin also diffuse reduced astrocytosis not associated staining. Collectively, these data suggest an age Alzheimer’s-related defect lysosomal/endosomal function could promote DNA fragmentation neurons glia similar found disease.

参考文章(65)
S. A. Frautschy, G. M. Cole, A. Baird, Phagocytosis and deposition of vascular beta-amyloid in rat brains injected with Alzheimer beta-amyloid. American Journal of Pathology. ,vol. 140, pp. 1389- 1399 ,(1992)
C Nordstedt, J Näslund, L O Tjernberg, A R Karlström, J Thyberg, L Terenius, The Alzheimer A beta peptide develops protease resistance in association with its polymerization into fibrils. Journal of Biological Chemistry. ,vol. 269, pp. 30773- 30776 ,(1994) , 10.1016/S0021-9258(18)47347-4
T C Saido, S A Frautschy, G M Cole, F Yang, M Irrizarry, B Hyman, K Hsiao, Microglial response to amyloid plaques in APPsw transgenic mice. American Journal of Pathology. ,vol. 152, pp. 307- 317 ,(1998)
Derik T. Weldon, Scott D. Rogers, Joseph R. Ghilardi, Matthew P. Finke, James P. Cleary, Eugene O’Hare, William P. Esler, John E. Maggio, Patrick W. Mantyh, Fibrillar β-Amyloid Induces Microglial Phagocytosis, Expression of Inducible Nitric Oxide Synthase, and Loss of a Select Population of Neurons in the Rat CNS In Vivo The Journal of Neuroscience. ,vol. 18, pp. 2161- 2173 ,(1998) , 10.1523/JNEUROSCI.18-06-02161.1998
J Ghiso, E Matsubara, A Koudinov, N H Choi-Miura, M Tomita, T Wisniewski, B Frangione, The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex. Biochemical Journal. ,vol. 293, pp. 27- 30 ,(1993) , 10.1042/BJ2930027
Asha Naidu, Diana Quon, Barbara Cordell, beta-Amyloid peptide produced in vitro is degraded by proteinases released by cultured cells. Journal of Biological Chemistry. ,vol. 270, pp. 1369- 1374 ,(1995) , 10.1074/JBC.270.3.1369
David Schubert, Serpins Inhibit the Toxicity of Amyloid Peptides European Journal of Neuroscience. ,vol. 9, pp. 770- 777 ,(1997) , 10.1111/J.1460-9568.1997.TB01425.X
M. R. Palmert, M. B. Podlisny, D. S. Witker, T. Oltersdorf, L. H. Younkin, D. J. Selkoe, S. G. Younkin, The beta-amyloid protein precursor of Alzheimer disease has soluble derivatives found in human brain and cerebrospinal fluid Proceedings of the National Academy of Sciences of the United States of America. ,vol. 86, pp. 6338- 6342 ,(1989) , 10.1073/PNAS.86.16.6338
F M LaFerla, J C Troncoso, D K Strickland, C H Kawas, G Jay, Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization. Journal of Clinical Investigation. ,vol. 100, pp. 310- 320 ,(1997) , 10.1172/JCI119536